UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 12.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,045,573 shares of the company's stock after selling 596,491 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 2.38% of Option Care Health worth $126,626,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Option Care Health by 84.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 70,119 shares of the company's stock valued at $2,195,000 after acquiring an additional 32,142 shares during the period. FORA Capital LLC acquired a new stake in Option Care Health in the third quarter valued at $1,178,000. CreativeOne Wealth LLC increased its holdings in shares of Option Care Health by 21.9% during the 3rd quarter. CreativeOne Wealth LLC now owns 14,380 shares of the company's stock worth $450,000 after acquiring an additional 2,585 shares during the last quarter. Townsquare Capital LLC increased its position in Option Care Health by 6.2% during the 3rd quarter. Townsquare Capital LLC now owns 72,675 shares of the company's stock worth $2,275,000 after buying an additional 4,258 shares during the period. Finally, Advantage Alpha Capital Partners LP bought a new stake in Option Care Health during the third quarter worth about $2,974,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Option Care Health Trading Up 1.3 %
Shares of NASDAQ:OPCH traded up $0.32 during trading hours on Monday, hitting $24.12. 2,276,178 shares of the company's stock traded hands, compared to its average volume of 1,553,045. The firm has a market capitalization of $4.10 billion, a P/E ratio of 20.27, a price-to-earnings-growth ratio of 2.46 and a beta of 1.32. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The business has a fifty day moving average price of $26.84 and a 200-day moving average price of $28.87.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on the stock. Jefferies Financial Group lowered shares of Option Care Health from a "buy" rating to a "hold" rating and reduced their price objective for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. JMP Securities increased their price objective on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a research report on Monday, September 30th. Truist Financial lowered their target price on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research note on Friday, November 1st. Finally, Bank of America downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and lowered their price objective for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Option Care Health currently has an average rating of "Moderate Buy" and an average target price of $30.83.
Get Our Latest Analysis on OPCH
Insider Transactions at Option Care Health
In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm's stock in a transaction on Friday, November 8th. The shares were bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.64% of the company's stock.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
